Department of Neonatology, Zekai Tahir Burak Maternity Teaching and Research Hospital, Ankara, Turkey.
J Clin Lab Anal. 2010;24(6):363-70. doi: 10.1002/jcla.20370.
Despite major advances in the management of newborn infants, neonatal sepsis (NS) remain important causes of neonatal morbidity and mortality in the newborn, mainly among preterm and low birth weight infants.
The aim of this study was to investigate the usefulness of neutrophil CD64 expression alone and together with other infection markers in NS.
Peripheral blood samples were taken from 109 neonates, who were categorized into three groups: proven or clinical sepsis (n=35); disease without infection (n=42); and healthy controls (n=32). Complete blood count with differential, interleukin-6 (IL-6), C-reactive protein (CRP), and cell surface expression of CD64 on neutrophils have been evaluated in a prospective manner as a diagnostic aid for NS.
Expression of CD64 was significantly enhanced in neonates with sepsis compared with newborns with disease without infection and healthy controls (P=0.001 and P=0.001, respectively). Cutoff values of IL-6, CRP, CD64(MFI), and CD64(i) were 24.9 pg/ml, 4.05 mg/l, 87.7, and 4.39, respectively. Sensitivity-negative predictive values of IL-6, CRP, and CD64(MFI)/CD64(i) were 80.0-90.6%, 80.0-88.8%, and 88.6-94.0%, respectively. Combining all three tests increased the sensitivity to 100%; however, specificity and positive predictive value decreased to 62.1 and 55.5%, respectively.
CD64 might be used either alone or combined with IL-6 and CRP for early diagnosis of NS. The advantages of CD64 when compared with IL-6 and CRP are rapid quantitation, very small blood volume required, and easy handling.
尽管新生儿管理取得了重大进展,但新生儿败血症(NS)仍然是新生儿发病率和死亡率的重要原因,主要发生在早产儿和低出生体重儿中。
本研究旨在探讨中性粒细胞 CD64 表达单独及与其他感染标志物联合在 NS 中的应用价值。
前瞻性采集 109 例新生儿外周血样本,分为三组:确诊或临床败血症(n=35);无感染疾病(n=42);健康对照组(n=32)。通过全血细胞计数、白细胞介素 6(IL-6)、C 反应蛋白(CRP)和中性粒细胞表面 CD64 表达,评估其作为 NS 诊断辅助的诊断价值。
与无感染疾病的新生儿和健康对照组相比,败血症新生儿的 CD64 表达明显增强(P=0.001 和 P=0.001)。IL-6、CRP、CD64(MFI)和 CD64(i)的截断值分别为 24.9pg/ml、4.05mg/l、87.7 和 4.39。IL-6、CRP 和 CD64(MFI)/CD64(i)的阴性预测值分别为 80.0-90.6%、80.0-88.8%和 88.6-94.0%。三种检测方法联合应用可将灵敏度提高至 100%,但特异性和阳性预测值分别降低至 62.1%和 55.5%。
CD64 可单独或与 IL-6 和 CRP 联合用于早期诊断 NS。与 IL-6 和 CRP 相比,CD64 的优势在于快速定量、所需血量少且易于操作。